Tiago Fauth

Stock Analyst at Wells Fargo

(0)
# 4678
Out of 5,320 analysts
163
Total ratings
29.37%
Success rate
-22.86%
Average return
44 Stocks
Name Action Price Target Current % Upside Ratings Updated
TECX Tectonic Therapeutic
Maintains: Overweight
112 101
17.89 464.56% 4 Mar 21, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Equal-Weight
275 287
232.88 23.24% 5 Mar 21, 2025
PLRX Pliant Therapeutics
Maintains: Equal-Weight
4 3
1.5 100% 2 Mar 4, 2025
VRNA Verona Pharma
Maintains: Overweight
74 93
60.15 54.61% 4 Feb 28, 2025
KROS Keros Therapeutics
Maintains: Overweight
28 26
14.28 82.07% 6 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 17
6.72 152.98% 1 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
85 107
69.49 53.98% 3 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 11
0.98 1022.45% 2 Jan 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
75 88
35.35 148.94% 7 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
8
3.05 162.3% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
4.43 103.16% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
56 68
48.19 41.11% 1 Nov 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 22
6.09 261.25% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
75
42.18 77.81% 1 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
350 380
284.24 33.69% 4 Aug 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
35 2
2.79 -28.32% 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 62
1.13 5386.73% 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
89
160.93 -44.7% 16 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
51
13.14 288.13% 3 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
120
58.67 104.53% 7 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
120
0.61 19572.13% 6 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
4
14.47 -72.36% 4 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 17
16.87 0.77% 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
3.09 353.07% 4 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
0.12 3233.33% 5 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
26
6.16 322.08% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 28
2.46 1038.21% 7 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 81
18.05 348.75% 11 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
139 200
199.92 0.04% 5 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
1
n/a n/a 3 Apr 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8
0.34 2252.94% 5 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
1.06 1220.75% 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 34
0.56 5971.43% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
150
2.39 6176.15% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
29
35.62 -18.59% 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
13
1.82 614.29% 1 Dec 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 13
1.33 877.44% 2 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
20.01 -0.05% 3 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
3 2
1.14 75.44% 4 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
297 340
595.45 -42.9% 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 18
39.95 -54.94% 2 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
102 98
99.99 -1.99% 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
265 259
273.92 -5.45% 1 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 42
19 121.05% 5 Nov 10, 2020